ENZ Key Stats
- Interesting ENZ Call For January 2014 May 20
- Enzo Biochem's Intellectual Property Protection To Attract Investor Attention In... May 13
- Enzo and NIH File Patent Application for Therapies, Diagnosis, and Prognosis for... May 7
- Could Enzo Biochem's Intellectual Property Lawsuits Be Worth Billions? Apr 28
- ENZO BIOCHEM INC Files SEC form 8-K, Changes in Registrant's Certifying Accounta... Apr 22
- ENZO BIOCHEM INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Mar 28
- The Market Likes Sangamo's Search For An HIV/AIDS Cure Mar 25
- Enzo Investors Have To Be In It For The Long Haul Mar 20
- Gain Capital posts quarterly loss, Inter Parfums profits up (Video) Mar 13
- ENZO BIOCHEM INC Files SEC form 8-K, Results of Operations and Financial Conditi... Mar 13
ENZ Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Enzo Biochem is up 7.77% over the last year vs S&P 500 Total Return up 31.69%, Life Technologies up 79.44%, and Affymetrix down 22.76%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Pro Ratings for ENZ
Pro Report PDF for ENZ
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download ENZ Pro Report PDF
Pro Strategies Featuring ENZ
Did Enzo Biochem make it into our Pro Portfolio Strategies?